Cost and utilization comparisons among propensity score-matched insulin lispro and regular insulin users.

Journal of managed care pharmacy : JMCP

Volumn 9, Issue 3, 2003, Pages 263-268

  Hall, Jennifer A ^a   Summers, Kent H ^a   Obenchain, Robert L ^a  

^a Ingenix Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; DRUG DERIVATIVE; INSULIN; INSULIN LISPRO;

AGE; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; DRUG COST; ECONOMICS; FEE; FEMALE; HEALTH INSURANCE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; STATISTICS; UNITED STATES;

ADMINISTRATION, ORAL; AGE FACTORS; COMORBIDITY; DRUG COSTS; FEES, PHARMACEUTICAL; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSURANCE, HEALTH; MALE; MANAGED CARE PROGRAMS; UNITED STATES;

EID: 0642276791     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2003.9.3.263     Document Type: Article

References (0)